Cargando…
Long-Term Medicaid Excess Payments from Alleged Price Manipulation of Generic Lorazepam
BACKGROUND: Cost savings from the use of generic drugs versus brand-name drugs are well known. Both private and public prescription drug plans encourage the use of generic drugs through a variety of mechanisms. The magnitude of cost savings for a given generic drug is dependent on the degree to whic...
Autores principales: | Bian, Boyang, Gorevski, Elizabeth, Kelton, Christina M.L., Guo, Jeff J., Boone, Jill E. Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437366/ https://www.ncbi.nlm.nih.gov/pubmed/22971204 http://dx.doi.org/10.18553/jmcp.2012.18.7.506 |
Ejemplares similares
-
Excess Medicaid Payments and the Stock Prices of Drug Companies
por: Grant, William C.
Publicado: (2012) -
ACE Inhibitor and ARB Utilization and Expenditures in the Medicaid Fee-For-Service Program from 1991 to 2008
por: Bian, Boyang, et al.
Publicado: (2010) -
Utilization and spending trends for antiretroviral medications in the U.S. Medicaid program from 1991 to 2005
por: Jing, Yonghua, et al.
Publicado: (2007) -
Medicaid Capitation Payments by State
por: Hsia, David C.
Publicado: (2019) -
Medicare and Medicaid Physician Payment Incentives
por: Burney, Ira L., et al.
Publicado: (1979)